Six weeks of strength endurance training decreases circulating senescence-prone T-lymphocytes in cytomegalovirus seropositive but not seronegative older women.

Community-dwelling older women Cytomegalovirus infection Exercise Immunosenescence Strength endurance training T-lymphocytes

Journal

Immunity & ageing : I & A
ISSN: 1742-4933
Titre abrégé: Immun Ageing
Pays: England
ID NLM: 101235427

Informations de publication

Date de publication:
2019
Historique:
received: 23 12 2018
accepted: 12 07 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 2 8 2019
Statut: epublish

Résumé

Ageing is associated with a decline in immune function termed immunosenescence. This process is characterized amongst others by less naive T-cells and more senescent phenotypes, which have been implicated in the pathogenesis of many age-related diseases. Thus far, reports regarding the long-term adaptation effects of exercise on T-cell phenotypes are scant and largely equivocal. These inconsistencies may be due to potential contributors to immunosenescence, particularly cytomegalovirus infection, which is considered a hallmark of T-cell senescence. Therefore, we sought to investigate the impact of cytomegalovirus serostatus on the distribution of peripheral T-cell subsets following long-term exercise in older women. One hundred women (aged 65 years and above) were randomized to 3 times/weekly training at either intensive strength training (3 × 10 repetitions at 80% of one-repetition maximum, We report for the first time that 6 weeks of strength endurance training significantly decreased senescence-prone T-cells along with a small increase in the number of CD8- naive T-cells in blood. The absolute counts of senescent-like T-cells decreased by 44% (from 26.03 ± 35.27 to 14.66 ± 21.36 cells/μL, In conclusion, the present study shows that strength endurance training leads to a reduction in circulating senescence-prone T-cells in cytomegalovirus seropositive older women. It remains to be established if monitoring of peripheral senescence-prone T-cells may have utility as cellular biomarkers of immunosenescence.

Sections du résumé

BACKGROUND BACKGROUND
Ageing is associated with a decline in immune function termed immunosenescence. This process is characterized amongst others by less naive T-cells and more senescent phenotypes, which have been implicated in the pathogenesis of many age-related diseases. Thus far, reports regarding the long-term adaptation effects of exercise on T-cell phenotypes are scant and largely equivocal. These inconsistencies may be due to potential contributors to immunosenescence, particularly cytomegalovirus infection, which is considered a hallmark of T-cell senescence. Therefore, we sought to investigate the impact of cytomegalovirus serostatus on the distribution of peripheral T-cell subsets following long-term exercise in older women.
METHODS METHODS
One hundred women (aged 65 years and above) were randomized to 3 times/weekly training at either intensive strength training (3 × 10 repetitions at 80% of one-repetition maximum,
RESULTS RESULTS
We report for the first time that 6 weeks of strength endurance training significantly decreased senescence-prone T-cells along with a small increase in the number of CD8- naive T-cells in blood. The absolute counts of senescent-like T-cells decreased by 44% (from 26.03 ± 35.27 to 14.66 ± 21.36 cells/μL,
CONCLUSIONS CONCLUSIONS
In conclusion, the present study shows that strength endurance training leads to a reduction in circulating senescence-prone T-cells in cytomegalovirus seropositive older women. It remains to be established if monitoring of peripheral senescence-prone T-cells may have utility as cellular biomarkers of immunosenescence.

Identifiants

pubmed: 31367217
doi: 10.1186/s12979-019-0157-8
pii: 157
pmc: PMC6657061
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Blood. 2000 May 1;95(9):2860-8
pubmed: 10779432
Ann N Y Acad Sci. 2000;899:363-74
pubmed: 10863553
Clin Infect Dis. 2000 Aug;31(2):578-85
pubmed: 10987724
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Immunol. 2002 Aug 15;169(4):1984-92
pubmed: 12165524
Eur J Appl Physiol. 2002 Aug;87(4-5):416-23
pubmed: 12172882
J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):636-43
pubmed: 12865480
Circulation. 1992 Jul;86(1):203-13
pubmed: 1319854
BMC Geriatr. 2004 Jul 23;4:6
pubmed: 15272934
Gerontology. 2005 Jul-Aug;51(4):253-65
pubmed: 15980654
J Gerontol A Biol Sci Med Sci. 2006 Apr;61(4):388-93
pubmed: 16611706
Ann N Y Acad Sci. 2006 May;1067:56-65
pubmed: 16803971
Exp Gerontol. 2007 Jun;42(6):563-70
pubmed: 17337145
Brain Behav Immun. 2008 Mar;22(3):324-38
pubmed: 17910910
J Geriatr Phys Ther. 2007;30(2):49-52
pubmed: 18171487
J Am Geriatr Soc. 2008 Nov;56(11):2045-52
pubmed: 19016938
Cancer Metastasis Rev. 2010 Jun;29(2):273-83
pubmed: 20390322
Trends Mol Med. 2010 May;16(5):238-46
pubmed: 20444648
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3
pubmed: 2052612
Antioxid Redox Signal. 2011 Apr 15;14(8):1551-85
pubmed: 20812785
Immun Ageing. 2010 Sep 07;7:13
pubmed: 20822513
Exerc Immunol Rev. 2010;16:40-55
pubmed: 20839490
Immunology. 2011 Sep;134(1):17-32
pubmed: 21711350
Biogerontology. 2012 Apr;13(2):169-81
pubmed: 22102004
Ageing Res Rev. 2012 Jul;11(3):404-20
pubmed: 22465452
Nat Rev Immunol. 2013 May;13(5):376-89
pubmed: 23584423
Med Sci Sports Exerc. 2014 Feb;46(2):257-67
pubmed: 23877375
Cytometry A. 2014 Jan;85(1):25-35
pubmed: 24124072
Nature. 2014 May 22;509(7501):439-46
pubmed: 24848057
Age (Dordr). 2014;36(5):9704
pubmed: 25128203
J Neuroinflammation. 2014 Sep 02;11:151
pubmed: 25178630
J Appl Physiol (1985). 2015 Jul 15;119(2):135-9
pubmed: 26023229
Exp Gerontol. 2015 Dec;72:29-37
pubmed: 26368538
Exerc Immunol Rev. 2016;22:8-27
pubmed: 26853134
Age (Dordr). 2016 Feb;38(1):24
pubmed: 26863877
J Am Med Dir Assoc. 2016 Jun 1;17(6):547-52
pubmed: 27052561
Nat Rev Immunol. 2016 Jun;16(6):367-77
pubmed: 27108521
Biomed Res Int. 2016;2016:5607507
pubmed: 27703976
Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):30-53
pubmed: 27755209
Eur J Appl Physiol. 2017 Mar;117(3):511-519
pubmed: 28168555
PLoS Comput Biol. 2017 Sep 26;13(9):e1005719
pubmed: 28949962
J Gerontol A Biol Sci Med Sci. 2019 Mar 14;74(4):480-488
pubmed: 29924317
Mech Ageing Dev. 1984 Nov;28(1):47-55
pubmed: 6513613

Auteurs

Hung Cao Dinh (H)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
5Department of Internal Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.

Ivan Bautmans (I)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
3Department of Geriatric Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Ingo Beyer (I)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
3Department of Geriatric Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Oscar Okwudiri Onyema (OO)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Keliane Liberman (K)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Liza De Dobbeleer (L)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Wim Renmans (W)

4Laboratory of Hematology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Sam Vander Meeren (S)

4Laboratory of Hematology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Kristin Jochmans (K)

4Laboratory of Hematology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Andreas Delaere (A)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Veerle Knoop (V)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Rose Njemini (R)

1Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
2Gerontology Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

Classifications MeSH